San Antonio, TXNCT07559474Now EnrollingIRB Ready

Hepatic Insufficiency Clinical Trial in San Antonio, TX

Access cutting-edge hepatic insufficiency treatment through this phase 1 clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.

Sponsored by Incyte Corporation

Quick Self-Assessment

See if you qualify for this San Antonio location

Preparing your pre-screening questions…

Expert Care in San Antonio

Access hepatic insufficiency specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hepatic insufficiency treatment provided free

Apply for This San Antonio Location

Check if you qualify for this hepatic insufficiency clinical trial in San Antonio, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Antonio

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Antonio site if eligible
  4. 4Begin participation

About This Hepatic Insufficiency Study in San Antonio

This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with moderate or severe hepatic impairment.

Sponsor: Incyte Corporation

Who Can Participate

Inclusion Criteria

Ability to comprehend and willingness to sign a written ICF for the study.
Aged 18 to 80 years, inclusive, at the time of signing the ICF.
Moderate or severe hepatic impairment based on CP score.
Medical findings consistent with the degree of hepatic dysfunction, determined by medical history, physical examination, vital sign measurements, 12-lead ECGs, and clinical laboratory determinations at screening or check-in (as applicable). Participants with abnormal findings considered not clinically significant by the medical monitor or investigator are eligible.
Body mass index of 18.0 to 43.0 kg/m2 (inclusive).
Willingness to avoid pregnancy or fathering children.

Exclusion Criteria

Participants who have a current, functioning organ transplant or are on the national transplant list and expected to receive a transplant within 3 months.
Tobacco or nicotine-containing product use of \> 10 cigarettes per day within 1 month before screening.
Participants who had a change in disease status within 30 days before screening, as documented by the participant's medical history, that is deemed clinically significant by the investigator.
Participants who have a history of paracentesis within 2 months prior to check-in.
Participants who required new medication or an increase in dose for hepatic encephalopathy within 3 months prior to check-in.
Participants who have a history of unstable diabetes mellitus (as evidenced by hemoglobin A1c ≥ 10.0%). Medications for treatment of diabetes mellitus must be reviewed and approved by the investigator and medical monitor. Participants who have a portal systemic shunt. Up to 3 participants with transjugular intrahepatic portosystemic shunt may be included.
Participants who had esophageal banding within 3 months prior to check-in or required any other treatment for gastrointestinal bleeding within 6 months prior to check-in. Other protocol-defined Inclusion/Exclusion Criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Antonio?

Yes, this clinical trial (NCT07559474) has an active research site in San Antonio, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hepatic Insufficiency Treatment Options in San Antonio, TX

If you're searching for hepatic insufficiency treatment options in San Antonio, TX, this clinical trial (NCT07559474) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Antonio research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced hepatic insufficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hepatic insufficiency clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in San Antonio, TX

See all interstitial cystitis clinical trials recruiting in San Antonio — not just this study.

Browse Interstitial Cystitis Trials in San Antonio →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in San Antonio?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Antonio, TX